← Open Payments lookup

BARBARA KALLENBACH-WATSON: Open Payments

NPI 1548281801 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,571 in 61 payments from 16 companies in 2025. Trend: 2023 $1,244 · 2024 $1,314 · 2025 $1,571

Food & beverage: $1,571
CompanyPaymentsAmount
Novo Nordisk Inc10$395
ABBVIE INC.11$299
AstraZeneca Pharmaceuticals LP3$148
PFIZER INC.7$136
Lilly USA, LLC7$119
SANOFI-AVENTIS U.S. LLC3$66
Boehringer Ingelheim Pharmaceuticals, Inc.3$60
GlaxoSmithKline, LLC.3$59
Exact Sciences Corporation3$55
SHIELD THERAPEUTICS INC2$48

Products named: Ozempic, AIRSUPRA, MOUNJARO, QULIPTA, JARDIANCE, TZIELD, LINZESS, ELIQUIS.

Industry payments across TX — which companies pay providers there.